Physician profile
John R Pasqual
NPI 1124000575
$378.25
in general payments reported to CMS, 2019-2025
5 companies · $73.75 in 2025
The $73.75 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.59 · 2021: $248 · 2022: $10.00 · 2023: $12.81 · 2025: $73.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salvin Dental Specialties, INC. | $248.10 | 2021 | |
| Zimvie INC. | $73.75 | 2025 | |
| Zimmer Biomet Holdings, INC. | $33.59 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.81 | 2023 | Seglentis |
| American Medical & Dental Supplies,INC. | $10.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pasqual listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.